These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2604981)

  • 21. [The importance of pain control with morphine for terminally ill patient care for at home].
    Ashino Y; Muto J; Ooigawa K; Kanno A; Inoue H; Kudo S
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():477-80; discussion 481. PubMed ID: 7528490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of controlled-released morphine on quality of life for cancer pain.
    Ferrell B; Wisdom C; Wenzl C; Brown J
    Oncol Nurs Forum; 1989; 16(4):521-6. PubMed ID: 2755859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects.
    Kaiko RF; Grandy RP; Oshlack B; Pav J; Horodniak J; Thomas G; Ingber E; Goldenheim PD
    Cancer; 1989 Jun; 63(11 Suppl):2348-54. PubMed ID: 2720580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.
    Wilkinson TJ; Robinson BA; Begg EJ; Duffull SB; Ravenscroft PJ; Schneider JJ
    Cancer Chemother Pharmacol; 1992; 31(3):251-4. PubMed ID: 1464164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW; Goughnour BR; White JA; Stewart JH
    CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation.
    Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
    J Clin Oncol; 1995 Jun; 13(6):1520-7. PubMed ID: 7751901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled-release morphine (MST Contin) in advanced cancer. The European experience.
    Hanks GW
    Cancer; 1989 Jun; 63(11 Suppl):2378-82. PubMed ID: 2655869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of controlled-release morphine sulfate (MS Contin) in Queensland 1990-1993.
    Richards AH
    Med J Aust; 1995 Aug; 163(4):181-2. PubMed ID: 7651250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
    Du X; Skopp G; Aderjan R
    Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MS Contin: a new string to morphine's bow?
    Stuart-Harris R
    Med J Aust; 1992 Nov; 157(10):654-5. PubMed ID: 1435403
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacoeconomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain.
    Zhang WZ; Yu WJ; Zhao XL; He BX
    Asian Pac J Cancer Prev; 2014; 15(20):8797-800. PubMed ID: 25374210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
    Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD
    Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of cancer pain with oral controlled-release morphine sulfate.
    Meed SD; Kleinman PM; Kantor TG; Blum RH; Savarese JJ
    J Clin Pharmacol; 1987 Feb; 27(2):155-61. PubMed ID: 3680567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avinza - 24-h sustained-release oral morphine therapy.
    Caldwell JR
    Expert Opin Pharmacother; 2004 Feb; 5(2):469-72. PubMed ID: 14996642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled release morphine tablets: a double-blind trial in patients with advanced cancer.
    Hanks GW; Twycross RG; Bliss JM
    Anaesthesia; 1987 Aug; 42(8):840-4. PubMed ID: 3310722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: control of cancer-related pain with MS contin.
    O'Bryan-Tear CG; Kinnersley N
    J Pain Symptom Manage; 1996 Sep; 12(3):145-6. PubMed ID: 8803374
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral opioids in the treatment of cancer pain.
    Zylicz Z; Twycross RG
    Neth J Med; 1991 Aug; 39(1-2):108-14. PubMed ID: 1660107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care.
    BMJ; 1996 Mar; 312(7034):823-6. PubMed ID: 8608293
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical observations on controlled-release morphine in cancer pain.
    Ventafridda V; Saita L; Barletta L; Sbanotto A; De Conno F
    J Pain Symptom Manage; 1989 Sep; 4(3):124-9. PubMed ID: 2778360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.